EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers?

Kaci Craft, Athina Amanor, Ian Barnett, Clarke Donaldson, Ignacio Anegon, Srinivas Madduri, Qiyi Tang iD, Moses T Bility

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073082 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kaci Craft und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Howard University College of Medicine, Washington, DC 20059, USA. Hauptthemen laut MEDLINE: Neoplasms, Cytomegalovirus, Cytomegalovirus Infections, Cytomegalovirus Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past three decades, immunodeficient mouse models carrying human immune cells, with or without human lymphoid tissues, termed humanized immune system (HIS) rodent models, have been developed to recapitulate the human immune system and associated immune responses. HIS mouse models have successfully modeled many human-restricted viral infections, including those caused by human cytomegalovirus (HCMV) and human immunodeficiency virus (HIV). HIS mouse models have also been used to model human cancer immunobiology, which exhibits differences from murine cancers in traditional mouse models. Variants of HIS mouse models that carry human liver cells, lung tissue, skin tissue, or human patient-derived tumor xenografts and human hematopoietic stem cells-derived-human immune cells with or without lymphoid tissue xenografts have been developed to probe human immune responses to infections and human tumors. HCMV-based vaccines are human-restricted, which poses limitations for mechanistic and efficacy studies using traditional animal models. The HCMV-based vaccine approach is a promising vaccine strategy as it induces robust effector memory T cell responses that may be critical in preventing and rapidly controlling persistent viral infections and cancers. Here, we review novel HIS mouse models with robust human immune cell development and primary and secondary lymphoid tissues that could address many of the limitations of HIS mice in their use as animal models for HCMV-based vaccine research. We also reviewed novel HIS rat models, which could allow long-term (greater than one year) vaccinology studies and better recapitulate human pathophysiology. Translating laboratory research findings to clinical application is a significant bottleneck in vaccine development; HIS rodents and related variants that more accurately model human immunology and diseases could increase the translatability of research findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCytomegalovirusCytomegalovirus InfectionsCytomegalovirus VaccinesAnimalsHumansRatsDisease Models, AnimalMice

Stichwörter der Autor:innen

HCMV-based vaccinesHIV vaccinesHIV/AIDS-animal modelshuman cancer xenograft modelshumanized immune system and rats

Substanzen

Cytomegalovirus Vaccines

Autor:innen und Institutionen

  • Department of Microbiology, Howard University College of Medicine, Washington, DC 20059, USA.
  • Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Bioengineering and Neuroregeneration Laboratory, Department of Surgery, University of Geneva, 1211 Geneva, Switzerland.

ORCID-Profile: Qiyi Tang

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIMHD NIH HHS
  • MTB
  • QT

Zitieren

APA

Craft, K., Amanor, A., Barnett, I., Donaldson, C., Anegon, I., Madduri, S., Tang, Q., & Bility, M. T. (2025). Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073082

Vancouver

Craft K, Amanor A, Barnett I, Donaldson C, Anegon I, Madduri S, et al. Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073082

BibTeX
@article{Craft2025,
  author = {Craft, Kaci and Amanor, Athina and Barnett, Ian and Donaldson, Clarke and Anegon, Ignacio and Madduri, Srinivas and Tang, Qiyi and Bility, Moses T},
  title = {Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers?},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073082}
}
Kostenlos starten →